MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

IntelliPharmaCeutics Intl Company Profile (NASDAQ:IPCI)

Consensus Ratings for IntelliPharmaCeutics Intl (NASDAQ:IPCI) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.67 (456.20% upside)

Analysts' Ratings History for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetActions
12/31/2015Maxim GroupLower Price TargetBuy$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015MackieSet Price TargetBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015Brean CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015NomuraDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/9/2015Q315($0.04)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/13/2015Q215($0.05)($0.06)$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/14/2015($0.08)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015($0.07)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/15/2014Q3($0.05)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/14/2014Q114$0.11$0.09$4.49 million$4.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2014($0.08)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/3/2013Q113($0.12)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
DateHeadline
06/19/16 08:50 AMCan Intellipharmaceutics International Inc. (NASDAQ:IPCI) Surprise Analysts this Quarter? - Investor Newswire
06/19/16 08:50 AMStrong Buy Calls Count For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 2 - Investor Newswire
06/06/16 04:30 PMIntellipharmaceutics Closes Public Offering for US$5.2 Million - [GlobeNewswire] - TORONTO, June 06, 2016-- Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release ...
05/31/16 09:01 AMOncoSec Medical Incorporated (NASDAQ:ONCS) went up 5.56%: IntelliPharmaCeutics International Inc. (NASDAQ ... - KC Register - OncoSec Medical Incorporated (NASDAQ:ONCS) went up 5.56%: IntelliPharmaCeutics International Inc. (NASDAQ ...KC RegisterOn 27 May, IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) announced the pricing of an underwritten public offering of 3,229,814 units of common shares and warrants, at a price of US$1.61 per unit, equal to the closing price of the Company's ...
05/31/16 09:01 AMIntelliPharmaCeutics International (NASDAQ:IPCI) went down -1.86%: Transocean Ltd. (NYSE:RIG), NVIDIA (NASDAQ ... - KC Register - IntelliPharmaCeutics International (NASDAQ:IPCI) went down -1.86%: Transocean Ltd. (NYSE:RIG), NVIDIA (NASDAQ ...KC RegisterOn 26 May, IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) announced that it intends to offer units of its common shares and warrants in an underwritten public offering. Dawson James Securities, Inc. is acting as sole bookrunner for the offering.
05/31/16 09:01 AMStock Review and Earnings Check on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - HNN - Stock Review and Earnings Check on Intellipharmaceutics International Inc. (NASDAQ:IPCI)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Intellipharmaceutics International Inc. (NASDAQ:IPCI) to report quarterly EPS of $-0.07. The company's next earnings report is expected ...and more »
05/31/16 09:01 AMSummary of Price Movements: Seattle Genetics, Inc. (NASDAQ:SGEN) , Intellipharmaceutics International Inc ... - Street Updates - Summary of Price Movements: Seattle Genetics, Inc. (NASDAQ:SGEN) , Intellipharmaceutics International Inc ...Street UpdatesIntellipharmaceutics International Inc. (NASDAQ:IPCI) after beginning at $1.55, closed at $1.58 by cutting down -1.86% in recent trading session. Most recent session's volume of 593.74 thousand shares greater than its average volume of 77.33 thousand ...and more »
05/30/16 09:52 PMNext Weeks Broker Price Targets For Intellipharmaceutics International Inc. (IPCI) - Share Trading News - Next Weeks Broker Price Targets For Intellipharmaceutics International Inc. (IPCI)Share Trading NewsIntellipharmaceutics International Inc. has a 50 day moving average of 1.97 and a 200 day moving average of 2.10. The stock's market capitalization is 39.04M, it has a 52-week low of 1.53 and a 52-week high of 3.87. The share price of the company (IPCI ...and more »
05/27/16 07:33 PMAnalysts Set 1-Year Price Target Of $8.666 On Intellipharmaceutics International Inc. (NASDAQ:IPCI) Stock - RealistInvestor.com - Analysts Set 1-Year Price Target Of $8.666 On Intellipharmaceutics International Inc. (NASDAQ:IPCI) StockRealistInvestor.comSell-side analysts reveal their outlook on Intellipharmaceutics International Inc. (NASDAQ:IPCI) stock. As of 2016-05-26, the stock has ABR of 1.43. This methodology prompts shareholders to invest in stock if it has a rating of 1. The ABR was known ...and more »
05/27/16 08:57 AMIntellipharmaceutics Announces Pricing of $5.2 Million Public Offering of Common Shares and Warrants - [at noodls] - May 27, 2016 TORONTO, May 27, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture ...
05/26/16 07:21 PMStock Reaching a Recent Low: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Wall Street Hints and News - Stock Reaching a Recent Low: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI)Wall Street Hints and NewsShares of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) continue to see declines as the stock moved -1.83% and recently touched a new 52-week low. The stock has been under pressure recently, as the company has been feeling the heat from their ...and more »
05/26/16 04:47 PMIntellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants - [at noodls] - May 26, 2016 TORONTO, May 26, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture ...
05/26/16 04:26 PM5:26 pm Intellipharmaceutics Intl files to offer units of common shares and warrants in an underwritten public offering -
05/24/16 07:13 PMEarnings Review and Stock Rundown for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Wall Street Hints and News - Earnings Review and Stock Rundown for Intellipharmaceutics International Inc. (NASDAQ:IPCI)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Intellipharmaceutics International Inc. (NASDAQ:IPCI) to post quarterly EPS of $-0.07. The company is expected to next publish earnings ...and more »
05/13/16 07:25 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Comprehensive Income At $0.2844 For Period Ended 2015-11-30 - Stocks Daily - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Comprehensive Income At $0.2844 For Period Ended 2015-11-30Stocks DailyFor the year ended 2015-11-30, Intellipharmaceutics International Inc. (NASDAQ:IPCI)comprehensive income was $0.2844 millions while for the quarter ended 2015-11-30, it was $0.2844 millions. Intellipharmaceutics International Inc. (NASDAQ:IPCI) posted ...Analyst Review: Intellipharmaceutics International Inc. (IPCI)Risers & Fallersall 3 news articles »
05/12/16 01:08 AMDialing Back Euphoria: The Intellipharmaceutics Prescription for Opioid Abuse - The Life Sciences Report: Can you describe Intellipharmaceutics International Inc.’s (IPCI:NASDAQ; I:TSX) core technology and how it applies to your abuse-deterrent oxycodone XR new drug application (NDA) product candidate, which you intend to market as ...
05/11/16 07:49 PMConsensus Rating Review for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - B.O.D.Y Confidential - Consensus Rating Review for Intellipharmaceutics International Inc. (NASDAQ:IPCI)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.43 on shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate ...and more »
05/04/16 07:26 PMAverage Analyst Rating for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - B.O.D.Y Confidential - Average Analyst Rating for Intellipharmaceutics International Inc. (NASDAQ:IPCI)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1.43 on Intellipharmaceutics International Inc. (NASDAQ:IPCI) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
04/29/16 07:53 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) EBITDA Yearly Stands At $-6.7356 Millions - Stocks Daily - Intellipharmaceutics International Inc. (NASDAQ:IPCI) EBITDA Yearly Stands At $-6.7356 MillionsStocks DailyFor the period ended 2015-11-30, Intellipharmaceutics International Inc. (NASDAQ:IPCI) comprehensive income was $0.2844 millions. For the three-month closed 2015-11-30, the comprehensive income was $0.2844 millions. Intellipharmaceutics ...Intellipharmaceutics International Inc. (IPCI) Latest Broker CoverageRisers & Fallersall 2 news articles »
04/28/16 01:38 AMCurrent Price Targets For Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers - Current Price Targets For Intellipharmaceutics International Inc. (IPCI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Intellipharmaceutics International Inc. (IPCI). The latest broker reports which are currently outstanding on Wednesday 27th of April state 0 analysts have a rating of ...
04/27/16 02:32 AMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating Recap - B.O.D.Y Confidential - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating RecapB.O.D.Y ConfidentialShares of Intellipharmaceutics International Inc. (NASDAQ:IPCI) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes ...
04/26/16 07:22 PMAnalyst Coverage: Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers - Analyst Coverage: Intellipharmaceutics International Inc. (IPCI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Intellipharmaceutics International Inc. (IPCI). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of ...
04/23/16 07:11 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Reported Basic Consolidated EPS Of $-0.3129 - Investor Newswire - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Reported Basic Consolidated EPS Of $-0.3129Investor NewswireFor the annual period closed 2015-11-30, Intellipharmaceutics International Inc. (NASDAQ:IPCI) received basic EPS of $-0.3129 from its parent firm. On quarterly basis, the contribution from the parent firm for the period ended 2015-11-30 was $-0.3129.and more »
04/22/16 09:21 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Analyst Rating Review - B.O.D.Y Confidential - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Analyst Rating ReviewB.O.D.Y ConfidentialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 3 analysts that have provided ratings for Intellipharmaceutics International Inc. (NASDAQ:IPCI). 2 have rated ...and more »
04/22/16 09:21 PMRecently Changed Price Targets On Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers - Recently Changed Price Targets On Intellipharmaceutics International Inc. (IPCI)Risers & Fallers02/24/2015 – Intellipharmaceutics International Inc. was downgraded to “neutral” by analysts at Nomura. The share price of Intellipharmaceutics International Inc. (IPCI) was up +4.26% during the last trading session, with a day high of 2.20. 54123 ...
04/21/16 09:07 PMBroker Outlook For Intellipharmaceutics International Inc. (IPCI) - Share Trading News - Broker Outlook For Intellipharmaceutics International Inc. (IPCI)Share Trading NewsThe most recently updated broker views and price targets issued for Intellipharmaceutics International Inc. (IPCI) are below. 12/31/2015 – Broker: Maxim Group Rating: buy New Target: 6 reiteration. 10/12/2015 – Broker: Brean Capital Rating: buy New ...
04/21/16 09:07 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating Recap - The Post - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating RecapThe PostShares of Intellipharmaceutics International Inc. (NASDAQ:IPCI) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes ...and more »
04/19/16 04:42 PMIntellipharmaceutics Reports Director Election Results - [at noodls] - April 19, 2016 TORONTO, April 19, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing ...
04/16/16 06:57 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI): Quick Look at Earnings - News Tribune - News TribuneIntellipharmaceutics International Inc. (NASDAQ:IPCI): Quick Look at EarningsNews TribuneWhen Intellipharmaceutics International Inc. (NASDAQ:IPCI) issues their next quarterly report on or near 2016-04-19, Wall Street analysts are predicting they will report earnings per share of $-0.07. This consensus EPS number is provided by Zacks ...
04/15/16 08:52 PMBroker Roundup For Intellipharmaceutics International Inc. (IPCI) - Share Trading News - Broker Roundup For Intellipharmaceutics International Inc. (IPCI)Share Trading News02/24/2015 – Intellipharmaceutics International Inc. was downgraded to “neutral” by analysts at Nomura. The share price of Intellipharmaceutics International Inc. (IPCI) was down -2.29% during the last trading session, with a day high of 2.22. 30211 ...Intellipharmaceutics Widens Q1 Loss on Weaker Revenues (NASDAQ:IPCI)Sonoran Weekly ReviewStock Update (NASDAQ:IPCI): IntelliPharmaCeutics Announces First Quarter 2016 ResultsSmarter Analystall 3 news articles »
04/15/16 08:52 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) Analyst Recommendation Outlook - Clinton Financial - Intellipharmaceutics International Inc. (NASDAQ:IPCI) Analyst Recommendation OutlookClinton FinancialThere are 3 analysts providing ratings for Intellipharmaceutics International Inc. (NASDAQ:IPCI). 2 have given the stock a “Strong Buy”, 0 rate it a “Buy”, 1 are rating the stock a Hold, and 0 are recommending “Sell”. Every recommendation can be mapped ...and more »
04/12/16 08:49 PMIntellipharmaceutics International Inc. (NASDAQ:IPCI) 50-Day Moving Average At $2.1991 - RealistInvestor.com - Intellipharmaceutics International Inc. (NASDAQ:IPCI) 50-Day Moving Average At $2.1991RealistInvestor.comThe technical analysis of Intellipharmaceutics International Inc. (NASDAQ:IPCI) stock highlights that it is trading $0.0108 points away +0.4893% from its 50-day MA of $2.1991. Further it is trading $0.1315 or +6.3280% away its 200-day MA of $2.0784.
04/12/16 08:49 PMEarnings Watch on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - RiversideGazette.com - Earnings Watch on Intellipharmaceutics International Inc. (NASDAQ:IPCI)RiversideGazette.comIntellipharmaceutics International Inc. (NASDAQ:IPCI) has a consensus earnings per share estimate for the current quarter of $-0.07 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-04-12 for the ...and more »
04/08/16 09:46 PMIs Intellipharmaceutics International Inc. (NASDAQ:IPCI) a Consensus Buy? - Clinton Financial - Is Intellipharmaceutics International Inc. (NASDAQ:IPCI) a Consensus Buy?Clinton FinancialEquity research firms covering public U.S companies have a workforce of analysts dedicating their time covering the most popular stocks. Their reports are delivered to institutional investors in order to help make investment decisions. The information ...and more »
04/08/16 09:46 PMAnalyst Review: Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers - Analyst Review: Intellipharmaceutics International Inc. (IPCI)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Intellipharmaceutics International Inc. (IPCI). According to the latest broker reports outstanding on Friday 8th of April, 2 analysts have a rating of “strong buy”, 1 ...
04/07/16 10:06 PMIntellipharmaceutics International Inc. (IPCI) Updated Broker Price Targets - Share Trading News - Intellipharmaceutics International Inc. (IPCI) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Intellipharmaceutics International Inc. (IPCI). The latest reports which are currently in issue on Thursday 7th of April state 2 analysts have a rating of “strong buy ...
04/06/16 09:11 PMAnalyst Ratings Check Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Business Standard Tribune - Analyst Ratings Check Intellipharmaceutics International Inc. (NASDAQ:IPCI)Business Standard TribuneCovering sell-side analysts have an average rating of 1.43 on shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on ...and more »
04/05/16 08:18 PMLatest Analyst Ratings For Intellipharmaceutics International Inc. (IPCI) - Share Trading News - Latest Analyst Ratings For Intellipharmaceutics International Inc. (IPCI)Share Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Intellipharmaceutics International Inc. (IPCI). The most recent broker reports which have been released note that 2 ...
04/05/16 08:18 PMEarnings View for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - RiversideGazette.com - Earnings View for Intellipharmaceutics International Inc. (NASDAQ:IPCI)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $-0.07 on shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on ...and more »
04/04/16 08:46 PMCan Analyst Rating Revive Intellipharmaceutics International Inc. (NASDAQ:IPCI) Stock? - Investor Newswire - Can Analyst Rating Revive Intellipharmaceutics International Inc. (NASDAQ:IPCI) Stock?Investor NewswireZacks Research has announced Intellipharmaceutics International Inc. (NASDAQ:IPCI) to have ABR of 1.43. Investors prefer to invest in the firms that tend to boast strong fundamentals. A group of investors recognizes the significance of research reports ...and more »
04/04/16 08:46 PMIntellipharmaceutics International Inc. (IPCI) Analyst Review - Risers & Fallers - Intellipharmaceutics International Inc. (IPCI) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of Intellipharmaceutics International Inc. (IPCI). According to the latest broker reports outstanding on Monday 4th of April, 2 analysts have a rating of “strong buy”, 1 ...Company Shares of Intellipharmaceutics International (NASDAQ:IPCI) Sinks -0.48%Street EditionIntellipharmaceutics Internation (NASDAQ:IPCI) Sellers Covered 2.52% of Their ShortsStock Callerall 3 news articles »
04/03/16 06:57 PMAfter Last Week What Do Analysts Think Of Intellipharmaceutics International Inc. (IPCI) - Share Trading News - After Last Week What Do Analysts Think Of Intellipharmaceutics International Inc. (IPCI)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Intellipharmaceutics International Inc. (IPCI). According to data from Reuters, 2 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts ...Company Shares of Intellipharmaceutics International (NASDAQ:IPCI) Sinks -0.48%Street EditionIntellipharmaceutics Internation (NASDAQ:IPCI) Sellers Covered 2.52% of Their ShortsStock Callerall 3 news articles »
04/01/16 07:51 PMShould Investors Buy Intellipharmaceutics International Inc. (NASDAQ:IPCI)? - Clinton Financial - Should Investors Buy Intellipharmaceutics International Inc. (NASDAQ:IPCI)?Clinton FinancialOut of the 3 analysts covering shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI), 2 rate it a “Strong Buy”, 0 rate it a “Buy”, 1 are advising to Hold the shares and 0 are saying “Sell”. Each recommendation can be mapped to an integer ...Intellipharmaceutics International Inc. (NASDAQ:IPCI): Analysts Take on EarningsUptick Analystall 3 news articles »
03/30/16 07:22 PMAverage Rating Watch Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Business Standard Tribune - Average Rating Watch Intellipharmaceutics International Inc. (NASDAQ:IPCI)Business Standard TribuneStreet analysts that cover Intellipharmaceutics International Inc. (NASDAQ:IPCI) presently have an average broker rating of 1.43 on the stock. This average rating comes from Zacks Research compiling polled analyst ratings taken into consideration.and more »
03/29/16 07:14 PMIntellipharmaceutics International Inc. (IPCI) Broker Views - Risers & Fallers - Intellipharmaceutics International Inc. (IPCI) Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Intellipharmaceutics International Inc. (IPCI). According to the latest broker reports outstanding on Tuesday 29th of March, 2 analysts have a rating of “strong buy ...
03/29/16 07:14 PMEarnings Outlook on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - RiversideGazette.com - Earnings Outlook on Intellipharmaceutics International Inc. (NASDAQ:IPCI)RiversideGazette.comAnalysts and investors will be looking forward to the next earnings release from Intellipharmaceutics International Inc. (NASDAQ:IPCI) which is scheduled to be on or around 2016-04-12 for the period ending 2016-02-29. Covering sell-side analysts have a ...and more »
03/28/16 06:52 PMIntellipharmaceutics International (IPCI) Short Interest Disclosure - SCSUCollegian - Intellipharmaceutics International (IPCI) Short Interest DisclosureSCSUCollegianIntelliPharmaCeutics International Inc. is up 2.46% in the last 3-month period. Year-to-Date the stock performance stands at 2.97%. Intellipharmaceutics International (NASDAQ:IPCI) witnessed a decline in the market cap on Thursday as its shares dropped ...
03/24/16 12:04 PMINTELLIPHARMACEUTICS INTERNATIONAL INC. Financials -
03/23/16 07:15 PMRating Update for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Business Standard Tribune - Rating Update for Intellipharmaceutics International Inc. (NASDAQ:IPCI)Business Standard TribuneSell-side analysts currently have an average broker rating of 1.43 on shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI). This rating averages all the recommendations from analysts that are taken into consideration by Zacks Research. Using ...
03/22/16 12:20 PMLooking Ahead to Earnings for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - RiversideGazette.com - Looking Ahead to Earnings for Intellipharmaceutics International Inc. (NASDAQ:IPCI)RiversideGazette.comInvestors and analysts will be looking ahead to Intellipharmaceutics International Inc. (NASDAQ:IPCI)'s next earnings report which is slated to be released sometime on or around 2016-04-12 for the period ending on 2016-02-29. Street analysts have a ...and more »
About IntelliPharmaCeutics Intl

IntelliPharmaCeutics Intl logoIntellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's Hypermatrix technology is a multidimensional controlled-release drug delivery platform is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed several drug delivery systems and a pipeline of products and product candidates at various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The Hypermatrix family of technologies include IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliPellets, IntelliShuttle and Point of Divergence Drug Delivery System (nPODDDS). Its products include Focalin XR, Effexor XR, Protonix, Lamictal XR, Keppra XR, Pristiq, Oleptro, and Lyrica, among others.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IPCI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.56
  • 50 Day Moving Average: $1.6671
  • 200 Day Moving Average: $2.0405
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $38.50M
  • Current Quarter EPS Consensus Estimate: $-0.3000 EPS
Additional Links:
IntelliPharmaCeutics Intl (NASDAQ:IPCI) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha